Oxford, UK : 5 - 7 July 2022
250 participants from 41 countries met at Churchill College, Cambridge, UK from 23-26 June 2019 for the 4th EACR Conference on Cancer Genomics.
250 participants | 41 countries | 135 posters presented | 7 proffered papers
98% were satisfied with the scientific quality of the conference
“I had a great opportunity to collaborate with a variety of researchers and Bio Tech companies. I think the conference was very welcoming, and the topics were close to my field of interest.”
“[The conference] was very well organized and focused. The scientific level of the speakers and participants was really high. The size of the conference is optimal for networking with other scientists.”
“The conference is a good size, with a good breadth of ‘hot’ topics discussed, and a variety of experts (ranging from junior to senior) to foster potential collaborations.”
Dietary requirements (in-person events only)
Please indicate any special dietary requirements here. We will try to cater to all dietary requirements and we will write to you if there is any problem.
Sharing your details with others
Please click below if you agree we can share your name, email and postal address with participants and exhibitors, who may use them to contact you.
Please note: you have selected NOT to share your details with participants and exhibitors.
You can click above to change this.
We will use the email address in your EACR account to communicate with you. However, during the checkout process you will need to enter the name and contact details of the person paying for your registration, if this is different to your own details. Please make sure you have this information to hand.
Terms and Conditions
Please read our Membership and Events Terms and Conditions before completing your registration.
Photography and video
Please note that we will be taking photographs and video at the conference for publicity and marketing purposes. If you do not wish to take part please inform the photographer.
The EACR is grateful for the continued support of its Industry Partners: